[1]谢益敏,刘海涛,顾杰,等.长链非编码RNA在膀胱癌中的研究进展[J].中华腔镜泌尿外科杂志(电子版),2018,12(01):63-66.[doi:10.3877/cma.j.issn.1674-3253.2018.01.016 ]
点击复制

长链非编码RNA在膀胱癌中的研究进展()
分享到:

中华腔镜泌尿外科杂志(电子版)[ISSN:1006-6977/CN:61-1281/TN]

卷:
12卷
期数:
2018年01期
页码:
63-66
栏目:
综述
出版日期:
2018-01-31

文章信息/Info

作者:
谢益敏12刘海涛3顾杰3焦志敏1陈兵海1孙浩1冯亚萍2
212000 镇江,江苏大学附属医院泌尿外科1;215400 江苏,太仓市中医医院泌尿外科2;212000 镇江,江苏大学生命科学院3
关键词:
膀胱癌 长链非编码RNA 分子标志物 研究进展
DOI:
10.3877/cma.j.issn.1674-3253.2018.01.016

参考文献/References:

[1] Chavan S, Bray F, Lortet-Tieulent J, et al. International vartiiaons in bladder cancer incidence and mortality[J]. Eur Urol, 2014, 6(61): 59-73.
[2] Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2013[J]. 2103, 63(1): 11-30.
[3] 韩苏军, 张思维, 陈万青, 等. 中国膀胱癌发病现状及流行趋势分析[J]. 癌症进展, 2013, 11(1): 89-95.
[4] Jacobs BL, Lee CT, Montie JE. Montie bladder cancer in 2010: who far have we Come?[J]. 2010, 60(4): 244-272.
[5] Okazaki Y, Furuno M, Kasukawa T, et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-legnth cDNAs[J]. Nature, 2002, 420(6915): 563-573.
[6] Wang KC, H. Y.chang molecular mechanisms of long noncoding RNAs[J]. Mol Cell, 2011, 43(6): 904.
[7] 张徐, 王梦瑶, 徐捡, 等. 长链非编码RNA 在乳腺癌中的研究进展[J]. 临床检验杂志, 2015, 33(6): 454-456.
[8] Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RAN controls muscle differentiation by functioning as a competing endogenous RNA[J]. Cell, 2011, 147(2): 358-369.
[9] Chen J, Miao Z, Xue B, et al. Long non-coding RNAs in urologic malignancies: functional roles and clinical translation[J]. J aCncer, 2016, 7(13): 1842-1855.
[10] Luo M, Li Z, Wang W, et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibitnig E-cadherin expression[J]. Cancer Lett, 2013, 333(2): 213-221.
[11] Hong HH, Hou LK, Pan X, et al. Long non-coding RNA UCA1 is a predictive biomarker of cancer[J]. Oncotarget, 2016, 7(28) :44442-44447.
[12] Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladdre carcinoma[J]. Clin Cancer Res, 2006, 12(16): 4851-4858.
[13] 赵义, 张尤历, 张行行, 等. 长链非编码RNA UCA1 对胰腺癌PANC-1 细胞系侵袭转移的影响[J]. 江苏大学学报: 医学版,2015, 25(4): 304-307.
[14] 王帆, 周戬平, 谢小娟, 等. LncRNA UCA1 对卵巢癌细胞侵袭及迁移的影响及机制[J]. 现代肿瘤医学, 2015, 23(1): 1-4.
[15] 王瑞国, 沈远, 李清, 等. DNA 损伤诱导的长链非编码RNAUCA1促进HeLa 细胞增殖[J]. 中国生物化学与分子生物学报,2015, 31 (5): 505-513.
[16] 张争, 郝瀚, 张崔建, 等. 新基因UCA1 用于膀胱癌诊断的临床应用价值[J]. 中华医学杂志, 2012, 92(6): 384-387.
[17] 金露, 李一帆, 陈独群, 等. miR-20b 在肾癌中的表达分析及临床意义研究[J]. 现代泌尿生殖肿瘤杂志, 2015, 7(2): 94-98.
[18] 王锐, 王宇长链非编码RNA UCA1 在肿瘤中的研究进展[J]. 海南医学, 2017, 28(1): 109-111.
[19] Wang F, Li X, Xie X, et al. UCA1, a non-protein-coding RNA upregulated in bladder carcinoma and embryo, influencing cell grwoth and promoting invasion[J]. FEBS Lett, 2008, 582(13): 1919-1927.
[20] 郑文雯, 张淑芳. 长链非编码RNA 在膀胱癌中的研究进展[J].现代肿瘤医学, 2015, 23(24): 3685-3690.
[21] Wu W, Zhang S, Li X, et al. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associate d1, a long non-coding RNA, in bladder cancer cells[J]. PLoS One, 2103, 8(9): e73920.
[22] 王宝森, 邢金春, 郑嘉欣. UCA1 在膀胱癌中的表达及临床意义[J]. 中国现代医生, 2010, 48(4): 16-18.
[23] 张争, 杨阳, 宋毅, 等. 尿路上皮癌胚抗原1(UCA1) 在人膀胱癌组织及膀胱癌细胞株中特异表达[J]. 中国生物化学与分子生物学报, 2012, 28(1): 66-70.
[24] Chen T, Xie W, Xie L, et al. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer[J]. Biochem Biophys Res Commun, 2015, 468(4): 666-670.
[25] Xie M, Nie FQ, Sun M, et al. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition[J]. J Transl Med, 2015, 13(1): 250.
[26] Zhang HM, Yang FQ, Yan Y, et al. High expression of long noncoding RNA SPRY4-IT1 predicts poor prognosis of clear cell renla cell carcinoma[J]. Int J Clin Exp Pathol, 2014, 7(9): 5801-580.9
[27] Zhao XL, Zhao ZH, Xu WC, et al. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer[J]. Int J Clin Exp Pathol, 2015, 8(2):1954-1960.
[28] Mao P, M Sun, D Shen, et al. The impact of long non-coding RNASPRY4-IT1 in proliferation and invasion of non-small cell lung cancer[J]. MODERN ONCOLOGY, 2017, 25(7), 1006-1010.
[29] 陈明伟, 黎健发, 庄成乐, 等. 长链非编码 RNA SPRY4-IT1 对膀胱癌生长的影响[J]. 安徽医科大学学报, 2016, 51(7): 978-983,984.
[30] 万中元. 长链非编码RNA 在退变人椎间盘髓核内的异常表达[D].陕西, 西京医院, 2014.
[31] Zhan YH, Li YF, Guan B, et al. Increased expression of long no-n coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma[J]. Oncotarget, 2017, 8(27): 44326-44334.
[32] Yang M, Zhai X, Xia BR, et al. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PNCA[J]. Tumour Biol, 2015, 36(10): 7615-7622.
[33] 彭绪峰, 张心如. 长链非编码RNA 在肾癌中的研究进展[J]. 现代泌尿外科杂志, 2017, 22(2): 145-148.
[34] 金桂花, 王丽娟, 朱青, 等. 长链非编码RNA 在膀胱癌中的研究进展[J]. 西部医学, 2013, 25(9): 1418-1421.
[35] Zhang R, Xia Y, Wang Z, et al. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer[J]. iBochem Biophys Res Commun, 2017, 490(2): 406-414.
[36] Liu D, Zhu Y, Pang J , et al. Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195[J]. J Cell Biochem, 2018, 119(2): 1368-1830.
[37] Lei R, Xue M, Zhang L, et al. Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP[J]. Onco Targets Ther, 2017, 10: 35-46
[38] 何必鸣, 陈锐, 孙颖浩. 长链非编码RNA 作为诊断前列腺癌的标志物的现状[J/CD]. 中华腔镜泌尿外科杂志( 电子版), 2015, 9(3):225-228.
[39] Han Y, Liu Y, Nie L, et al. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder[J]. Urology, 2013,81(1): 209.e1-209.e7.
[40] Ying L, Huang Y, Chen H, et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer[J.] Mol Biosyst, 2013, 9(3): 407-411.
[41] Ying L, Chen Q, Wang Y, et al. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition[J]. Mol Biosyst, 2012, 8(9): 2289-2294.
[42] Chen MW, Li JF, Zhuang CL, et al. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer[J]. Oncotraget,2017, 8(17): 28176-28186.
[43] 李凯, 魏雪栋, 张光波, 等. XIAP 在膀胱癌中表达的研究进展[J].江苏医药, 2016, 42(11): 1274-1276.
[44] Zhou Y, Zhang X, A. Klibanski MEG3 noncoding RNA:a tumor suppressor[J]. J Mol Endocrinol, 2012, 48(3): 45-53.
[45] 李芬, 王美英, 张振. 长链非编码 RNA 与膀胱癌的研究进展[J].检验医学与临床, 2016, 13(5): 703-706.
[46] 林洋, 金刚, 田玉新, 等. 腹腔镜下保留前列腺的膀胱全切除术[J]. 中华腔镜泌尿外科杂志( 电子版), 2017, 11(2): 96-100.

相似文献/References:

[1]刘春晓,郑少波,徐亚文,等.腹腔镜下根治性全膀胱切除术100例总结[J].中华腔镜泌尿外科杂志(电子版),2007,(01):19.
 LIU Chun-xiao,ZHENG Shao-bo,XU Ya-wen,et al.Laparoscopic radical cystectomy (report of 100 cases)[J].,2007,(01):19.
[2]司徒灿,关永祥,谢国均,等.腹腔镜下全膀胱切除原位回肠新膀胱术(5例报告)[J].中华腔镜泌尿外科杂志(电子版),2007,(02):103.
 SITU Can,GUAN Yong-xiang,XIE Guo-jun,et al.Laparoscopic assisted radical cystectomy with ileal neobladder in 5 cases of invasive transitional cell cancer of bladder[J].,2007,(01):103.
[3]龙兆麟,黄健,华庆生,等.腹腔镜全膀胱切除-原位回肠膀胱术(5例报告)[J].中华腔镜泌尿外科杂志(电子版),2008,(04):12.
[4]王晓庆,卢绩,陈岐辉,等.Livin基因在浅表性膀胱癌中的表达及其与肿瘤复发的关系[J].中华腔镜泌尿外科杂志(电子版),2010,(02):148.
[5]肖峻,陈凌武,陈炜,等.直线切割闭合器在腹腔镜膀胱癌根治术肠道吻合中的应用[J].中华腔镜泌尿外科杂志(电子版),2010,(06):441.
 XIAO Jun,CHEN Ling-wu,CHEN Wei,et al.Application of gastrointestinal anastomosis staplers during alimentary reconstruction of laparoscopic radical cystectomy[J].,2010,(01):441.
[6]关健仪,马雪霞,赵敏,等.改良单孔腹腔镜下根治性膀胱前列腺切除轧原位回肠新膀胱术围手术期护理[J].中华腔镜泌尿外科杂志(电子版),2012,(06):482.
 GUAN Jian-yi,MA Xue-xia,ZHAO Min,et al.Perioperative nursing care of hybrid laparo-endoscopic single-site surgery for radical cystoprostatectomy and orthotopic ileal neobladder[J].,2012,(01):482.
[7]孙其鹏 狄金明 湛海伦 杨飞 蔡佳荣 李腾成 周祥福.根治性膀胱切除术前淋巴结转移预测的相关指标分析[J].中华腔镜泌尿外科杂志(电子版),2014,(05):334.[doi:10.3877/cma.j.issn.1674-3253.2014.05.005 ]
 Sun Qipeng,DiJinming,Zhan Hailun,et al.Precystectomy nomograms for prediction oflymphnode metastases[J].,2014,(01):334.[doi:10.3877/cma.j.issn.1674-3253.2014.05.005 ]
[8]顾志波,郝林,陆明,等.光动力纳米载体联合si-P3H4治疗膀胱癌的初步探索[J].中华腔镜泌尿外科杂志(电子版),2023,17(06):633.[doi:10.3877/cma.j.issn.1674-3253.2023.06.017]
 [J].,2023,17(01):633.[doi:10.3877/cma.j.issn.1674-3253.2023.06.017]
[9]陈明坤,薛康颐,黄志鹏,等.广东省医学会泌尿外科疑难病例多学科会诊(第11期)——膀胱癌综合治疗9年后现腹股沟淋巴结转移[J].中华腔镜泌尿外科杂志(电子版),2023,17(06):663.[doi:10.3877/cma.j.issn.1674-3253.2023.06.025]
 [J].,2023,17(01):663.[doi:10.3877/cma.j.issn.1674-3253.2023.06.025]
[10]张逸,张继,栾成明,等.肿瘤定量参数对VI-RADS评分系统评估膀胱癌的辅助价值[J].中华腔镜泌尿外科杂志(电子版),2024,18(01):41.[doi:10.3877/cma.j.issn.1674-3253.2024.01.008]
 [J].,2024,18(01):41.[doi:10.3877/cma.j.issn.1674-3253.2024.01.008]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81402100),江苏省卫计委青年基金(Q201408),江苏省青年医学人才项目(QNRC2016840),镇江市科技计划(SH2016031,SH2014026),太仓市科技计划(TC2016SFYL20)
通讯作者:陈兵海,Email:chenbhny@163.com
更新日期/Last Update: 2018-02-25